✦ LIBER ✦

Tacrolimus Plus Low-Dose Mycophenolate Mofetil in Renal Transplant Recipients: Better 2-Year Graft and Patient Survival Than With a Higher Mycophenolate Mofetil Dose

✍ Scribed by H. Kocak; U. Yakupoglu; G. Uslu Karatas; A. Yavuz; A. Gurkan; O. Erdogan; F.F. Ersoy; G. Yakupoglu; A. Demirbas; M. Tuncer

Book ID: 116931469
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 97 KB
Volume: 37
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2005.07.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary immunosuppression with tacrolimu

Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients

✍ S. Yeung; W.K. Tsang; K.L. Tong; S.H. Wong; W. Lee; H.L. Tang; H.W.H. Chan; A.Y. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Low-dose and rapid steroid withdrawal in

Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil

✍ E Sola; M.J Alférez; M Cabello; D Burgos; M González Molina 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Tacrolimus and mycophenolate mofetil in

Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial

✍ J Miller 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Evaluation of renal function in liver tr

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial

✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n

Cardiovascular Risk Profile in Kidney Tr

Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine

✍ G. Spagnoletti; F. Citterio; E. Favi; E. Rossi; F. Delreno; I. De Santis; M.P. S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Prospective Clinical Trial Comparing Two

Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up

✍ E. Favi; F. Citterio; G. Spagnoletti; A. Gargiulo; F. Delreno; J. Romagnoli; M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 113 KB